Pancreatic Ductal Adenocarcinoma (PDAC) Archives

Promising first results of mitazalimab in metastatic pancreatic ductal adenocarcinoma

Presented By

Dr Teresa Macarulla, Vall d’Hebron University Hospital, Spain

Trial

Phase 1/2, OPTIMIZE-1

Conference

ESMO GI 2024

Type

Peer-reviewed article

21 August 2024 11:50

Encouraging preliminary data for glecirasib in pancreatic ductal adenocarcinoma

Presented By

Dr Jian Li, Peking University Cancer Hospital and Institute, China

Trial

Phase 1/2, JAB-21822-1001, JAB-21822-1002

Conference

ASCO GI 2024

Type

News article

13 February 2024 12:51

ALPACA: Promising results for dose de-escalated regimen of gemcitabine/nab-paclitaxel in metastatic PDAC

Presented By

Prof. Frank Kullmann, Hospital Weiden, Germany

Trial

Phase 2, ALPACA (AIO-PAK-0114)

Conference

ASCO GI 2024

Type

News article

13 February 2024 12:48

First-line NALIRIFOX superior to standard treatment in mPDAC

Presented By

Prof. Zev Wainberg, University of California Los Angeles, CA, USA

Trial

Phase 3, NAPOLI-3

Conference

ASCO GI 2023

Type

Peer-reviewed article

17 March 2023 09:37

Metal stents are better than plastic for endoscopic biliary drainage

Presented By

Dr Anouk Latenstein, Amsterdam University Medical Center, the Netherlands

Trial

DROP

Conference

UEGW 2019

Type

Peer-reviewed article

23 October 2019 20:12

First-in-human study shows IL1RAP-targeting drug safe in solid tumours

Presented By

Dr Ahmad Awada, Institut Jules Bordet, Belgium

Conference

ASCO 2019

Type

Peer-reviewed article

15 July 2019 13:58